Volume | 89,015 |
|
|||||
News | - | ||||||
Day High | 13.065 | Low High |
|||||
Day Low | 12.17 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Alto Neuroscience Inc | ANRO | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
12.92 | 12.17 | 13.065 | 12.47 | 12.82 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
1,548 | 89,015 | $ 12.49 | $ 1,112,079 | - | 12.17 - 24.00 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:00:00 | 4,361 | $ 12.47 | USD |
Alto Neuroscience Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
333.59M | 26.79M | - | 0 | -36.31M | -1.36 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Alto Neuroscience News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ANRO Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 14.60 | 14.83 | 12.17 | 13.67 | 87,871 | -2.13 | -14.59% |
1 Month | 13.49 | 16.535 | 12.17 | 14.16 | 86,403 | -1.02 | -7.56% |
3 Months | 13.46 | 18.3499 | 12.17 | 14.86 | 172,501 | -0.99 | -7.36% |
6 Months | 22.00 | 24.00 | 12.17 | 15.87 | 213,394 | -9.53 | -43.32% |
1 Year | 22.00 | 24.00 | 12.17 | 15.87 | 213,394 | -9.53 | -43.32% |
3 Years | 22.00 | 24.00 | 12.17 | 15.87 | 213,394 | -9.53 | -43.32% |
5 Years | 22.00 | 24.00 | 12.17 | 15.87 | 213,394 | -9.53 | -43.32% |
Alto Neuroscience Description
Alto Neuroscience is a clinical-stage biopharmaceutical company with a mission to redefine neuropsychiatric care by leveraging neurobiology to develop personalized and highly effective treatment options. Through our AI-enabled biomarker platform, we combine rich sources of information on patients¿ brain activity and behavior to better identify which patients are more likely to respond to our novel product candidates. |